Chlorambucil plus rituximab as front-line therapy for elderly and/or unfit chronic lymphocytic leukemia patients:
Luca Laurenti1, Idanna Innocenti2, Francesco Autore2
1Università Cattolica del Sacro Cuore, Roma, Italy luca.laurenti@unicatt.it.
Haematologica
|June 10, 2017
Abstract
No abstract available in PubMed .
More Related Videos
14:04Neutrophil Isolation and Analysis to Determine their Role in Lymphoma Cell Sensitivity to Therapeutic Agents
Published on: March 25, 2016
15.9K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
22.6K
